Test Your Myasthenia Gravis Knowledge
Reviewed by: HU Medical Review Board | Last reviewed: June 2026 | Last updated: June 2026
Navigating the complexities of myasthenia gravis (MG) requires a delicate balance between precise symptomatic control, timely immunomodulation, and vigilant crisis prevention. This concise quiz is designed to challenge and refine your clinical decision-making. Review the questions below to test your knowledge.
Clinical Challenge
Based on the Update of the International Consensus Guidance for Management of Myasthenia Gravis, which patient profile represents the strongest clinical indication for a thymectomy in the absence of an underlying thymoma?
Clinical Challenge
A patient with generalized MG (gMG) is admitted to the ICU with severe respiratory distress and profound weakness. They have been taking escalating, high doses of pyridostigmine. Which clinical sign or constellation of symptoms is most useful in differentiating a Myasthenic Crisis from a Cholinergic Crisis?
Clinical Challenge
Patients with Muscle-Specific Kinase (MuSK) antibody-positive MG display a distinct clinical phenotype. According to global consensus guidelines, which statement correctly describes the specialized management approach required for MuSK-positive MG?
Clinical Challenge
A 50-year-old male with gMG requires empiric antibiotic therapy for a severe bacterial infection. Which class of antibiotics carries a prominent FDA boxed warning specifically citing the risk of severe exacerbation of muscle weakness and triggering a myasthenic crisis?
Clinical Challenge
A clinician highly suspects ocular MG in a 60-year-old male presenting with fluctuating diplopia and ptosis. Initial serological testing for AChR and MuSK antibodies is negative, and standard repetitive nerve stimulation (RNS) of the distal extremity muscles shows no decremental response. Which diagnostic study is most appropriate to perform next due to its superior diagnostic sensitivity?